Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 1/2 1

Status

Terminated 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Lymphoid 1Gastrointestinal 1

Conditions

Pain 4Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain, Postoperative 2Agnosia 2Acute Pain 2Rectal Neoplasms 1Prostatic Neoplasms 1Otolaryngeal Cancer 1Lymphoma, Follicular 1Ileus 1Gastrointestinal Neoplasms 1Emergence Delirium 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Constipation 1Colonic Neoplasms 1Anxiety Disorders 1

Interventions

Ketamine 2Diclofenac 2Acetaminophen 2Surveys and Questionnaires 1Psychotherapy 1Passive Cutaneous Anaphylaxis 1Oxycodone 1Gabapentin 1Fentanyl 1Anesthesia, General 1Analgesia, Patient-Controlled 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Acute Pain × Ketamine × Clear all
NCT06077487 2025-05-21

Ketamine-assisted Therapy for Advanced GI Cancer

University of California, San Francisco

Phase 4 Terminated
1 enrolled 10 charts
Gastrointestinal

Gastrointestinal Neoplasms, Acute Pain

NCT03959852 2020-09-11

Sub-Dissociative Ketamine and Fentanyl to Treat Moderate to Severe Pain

Mercy Health Ohio

Phase 4 Terminated
6 enrolled
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡